Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Tissue & Tissue Products

Tissue & Tissue Products

                        Exemptions and Alternatives
          Questions about Tissues Home
          Vaccines, Blood & Biologics
          Tissue & Tissue Products
          Tissue Reference GroupTissue & Tissue Products Tissue Reference Group
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThe Tissue Reference Group (TRG) was created as specified in the "Proposed Approach to the Regulation of Cellular and Tissue-based Products" published by FDA in February of 1997. The purpose of the TRG is to provide a single reference point for product specific questions received by FDA (either through the Centers, or from the Office of Combination Products) concerning jurisdiction and applicable regulation of human cells, tissues and cellular and tissue-based products (HCT/Ps).

The TRG is composed of three representatives from the Center for Biologics Evaluation and Research (CBER) and three from the Center for Devices and Radiological Health (CDRH), including the product jurisdiction officer at each Center. An executive secretary handles administrative functions for the TRG. A liaison from the Office of Combination Products and from the Office of the Chief Counsel attends meetings. Other FDA staff attend meetings as needed to discuss issues related to HCT/Ps in their area of expertise.

The TRG provides recommendations to the Centers and through the Centers to the Office of Combination Products, which then communicates with the sponsor. These recommendations are based on the information known at the time and are subject to change.

If you have questions or wish to send a request for recommendation to the Tissue Reference Group, please contact the Executive Secretary for the Tissue Reference Group, Division of Human Tissues, Office of Tissues and Advanced Therapies (OTAT) by FAX at 301-595-1303 or by email at TissueReferenceGroup@fda.hhs.gov. Submissions to the TRG can be emailed or mailed to the Tissue Reference Group at the Center for Biologics Evaluation and Research (CBER), Office of Tissues and Advanced Therapies (OTAT), Food and Drug Administration, 10903 New Hampshire Avenue, Building 71, Room G112, Silver Spring, MD 20993-0002.

To facilitate review of your inquiry by the TRG, you may want to include the following:

your name and contact information, and if applicable, the name and contact information of the party you represent;
	manufacturer of the product;
	any proprietary names and common names associated with the product;
	source of the product including how the HCT/P is recovered;
	a clear, step-by-step description of how the product is processed, packaged (including the range of product sizes, when applicable), and stored;
	the way the product is to be used and product labeling, including package inserts and any Instructions for Use documents; and
	how the product meets all the criteria in 21 CFR 1271.10(a).**NOTE**: The TRG may request additional or clarifying information if it is needed to make a recommendation. **Inconsistencies in the information submitted may cause delays**.

Related Information

SOPP 8004: Tissue Reference Group

                                                                                  Content current as of:
      01/11/2023
              
              
Regulated Product(s)
		 BiologicsTissue & Tissue Products

          
                        Exemptions and Alternatives
          Questions about Tissues
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop